One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/j.radonc.2023.109996
Volume 189, December 2023, 109996
Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: A systematic review and meta-analysis of randomized controlled trials
Henry C.Y. Wong a,1,*, Shing Fung Lee b,c,1, Adrian Wai Chan c, Saverio Caini d, Peter Hoskin e,f, Charles B. Simone II g, Peter Johnstone h, Yvette van der Linden i,j, Joanne M. van der Velden k, Emily Martin l, Sara Alcorn m, Candice Johnstone n, J. Isabelle Choi g, Gustavo Nader Marta o,p, Eva Oldenburger q, Srinivas Raman r, Agata Rembielak f,s, Vassilios Vassiliou t, Pierluigi Bonomo u, Quynh-Nhu Nguyen v, Edward Chow w, Samuel Ryu
doi : 10.1016/j.radonc.2023.109914
Volume 189, December 2023, 109914
Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium
Brian V. Balgobind a,*, Jorrit Visser a, Melanie Grehn b, Marianne Marquard Knap c, Dirk de Ruysscher d, Mario Levis e, Pino Alcantara f, Judit Boda-Heggemann g, Marcus Both h, Salvatore Cozzi i,j, Jakub Cvek k, Edith M.T. Dieleman a, Olgun Elicin l, Niccol`o Giaj-Levra m, Rapha¨el Jumeau n, David Krug b, Manuel Algara L´opez o, Michael Mayinger p, Felix Mehrhof q, Marcin Miszczyk r, Maria Jos´e P´erez-Calatayud s, Luuk H.G. van der Pol t, Peter-Paul van der Toorn u, Viviana Vitolo v, Pieter G. Postema w, Etienne Pruvot x, Joost C. Verhoeff t, Oliver Blanck
doi : 10.1016/j.radonc.2023.109949
Volume 189, December 2023, 109949
Favourable outcomes with an initial active surveillance strategy for asymptomatic radiation-induced meningiomas in long-term survivors of paediatric and young adult malignancies
Mary Xu a,c, Arian Lasocki b,c, Mathias Bressel d, Natalie Goroncy e, Greg Wheeler a,c, Mary Dwyer a, Kirsty Wiltshire a, John F. Seymour c,f, Neda Haghighi a, Kylie Mason f, Damien Tange g, Belinda A. Campbell
doi : 10.1016/j.radonc.2023.109916
Volume 189, December 2023, 109916
External validation of three prognostic scores for brain metastasis velocity in patients treated with intracranial stereotactic radiotherapy
Sebastian M. Christ a,*,1, Kim Borsky b,1, Johannes Kraft a,c, Simon Frei b, Jonas Willmann a,d, Maiwand Ahmadsei a, Corinna Kirchner a, Luisa Sabrina Stark Schneebeli a, Federico Camilli a,e, Stephanie Tanadini-Lang a, Rifaquat Rahman f, Ayal A. Aizer f, Matthias Guckenberger a, Nicolaus Andratschke a, Michael Mayinger
doi : 10.1016/j.radonc.2023.109917
Volume 189, December 2023, 109917
Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy
Jacob Hall a,*, Kevin Lui b, Xianming Tan c,1, John Shumway a, Frances Collichio d, Stergios Moschos d, Soma Sengupta e, Rekha Chaudhary f, Carolyn Quinsey g, Sivakumar Jaikumar g, Jonathan Forbes h, Norberto Andaluz h, Mario Zuccarello h, Timothy Struve b, Ralph Vatner b, Luke Pater b, John Breneman b, Ashley Weiner a, Kyle Wang b, Colette Shen
doi : 10.1016/j.radonc.2023.109920
Volume 189, December 2023, 109920
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors
Karl Bordeau a, Morgan Michalet a, Val´erie Dorion a, Aïcha Keskes a, Simon Valdenaire a, Pierre Debuire a, Marie Cantaloube a, Morgane Cabaill´e a, Roxana Draghici a, Marc Ychou b, Eric Assenat c, Marta Jarlier d, Sophie Gourgou d, Boris Guiu e, Jos´e Ursic-Bedoya f, Norbert Aill`eres a, Pascal Fenoglietto a, David Azria a, Olivier Riou
doi : 10.1016/j.radonc.2023.109912
Volume 189, December 2023, 109912
Management of unknown primary head and neck cancer with radiation therapy in the era of human papillomavirus (HPV): No longer cutting down the tree to get an apple
Allen M. Chen
doi : 10.1016/j.radonc.2023.109952
Volume 189, December 2023, 109952
Impact of consensus guidelines on delineation of primary tumor clinical target volume (CTVp) for head and neck cancer: Results of a national review project
Heleen Bollen a,*,1, Akos Gulyban b,c,1, Sandra Nuyts
doi : 10.1016/j.radonc.2023.109915
Volume 189, December 2023, 109915
Correlation between hippocampal radiation doses and psychological condition for patients with stage T1-2 nasopharyngeal carcinoma
Xiujuan Gai a,b,d,1, Li Su a,b,c,1, Shiqi Huang a,b, Jiang Zeng a,b,c, Feibao Guo a,b,c, Chuanshu Cai a,b,c, Wenlong Lv a,b,c, Feng Liu a,b,c, Shan Li a,b,c, Jinsheng Hong
doi : 10.1016/j.radonc.2023.109942
Volume 189, December 2023, 109942
Prognostic value of metastatic cervical lymph node stiffness in nasopharyngeal carcinoma: A prospective cohort study
Xue-Song Sun a,b,1, Jian-Wei Wang a,c,1, Feng Han a,c,1, Ru-Hai Zou a,c,1, Zhen-Chong Yang a,c, Shan-Shan Guo a,b, Li-Ting Liu a,b, Qiu-Yan Chen a,b,*, Lin-Quan Tang a,b,*, Hai-Qiang Mai
doi : 10.1016/j.radonc.2023.109939
Volume 189, December 2023, 109939
A Rulefit-based prognostic analysis using structured MRI report to select potential beneficiaries from induction chemotherapy in advanced nasopharyngeal carcinoma: A dual-centre study
Shuqi Li a,1, Weijing Zhang a,1, Baodan Liang a,1, Wenjie Huang a,1, Chao Luo a, Yuliang Zhu b, Kit Ian Kou c, Guangying Ruan a, Lizhi Liu a, Guoyi Zhang d,*, Haojiang Li
doi : 10.1016/j.radonc.2023.109943
Volume 189, December 2023, 109943
Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy
Chia-Hsin Lin a, Jiun-Lin Yan b,c, Wing-Keen Yap a, Chung-Jan Kang d, Yun-Chen Chang d, Tsung-You Tsai d, Kai-Ping Chang d, Chun-Ta Liao d, Cheng-Lung Hsu e, Wen-Chi Chou e, Hung- Ming Wang e, Pei-Wei Huang e, Kang-Hsing Fan f, Bing-Shen Huang a,g, Joseph Tung-Chieh Chang a,h, Shu-Ju Tu i,j,1,*, Chien-Yu Lin
doi : 10.1016/j.radonc.2023.109938
Volume 189, December 2023, 109938
Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy
Gowoon Yang a, Hong In Yoon a, Joongyo Lee a, Jihun Kim b, Hojin Kim a, Jaeho Cho a, Chang Geol Lee a, Jee Suk Chang a, Yeona Cho b, Jin Sung Kim a, Kyung Hwan Kim
doi : 10.1016/j.radonc.2023.109934
Volume 189, December 2023, 109934
Treatment options for stage III-N2 pulmonary lymphoepithelioma-like carcinoma: A retrospective cohort study
Zan Hou a,b,1, Ying Guo c,1, Xiujiao Shen d,1, Baiqiang Dong a,b, Mingchun Li e,f, Mingdian Wang d, Qiong Li g, Shining Li h,*, Runzhe Chen a,b,*, Ming Chen
doi : 10.1016/j.radonc.2023.109937
Volume 189, December 2023, 109937
Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21–10)
Jun Yeong Song a,b,1, Sung Ho Moon c,1, Yang-Gun Suh c, Jong-Hoon Kim d, Dongryul Oh e, Jae Myoung Noh e, Jae-Uk Jeong f, Ick Joon Cho f, Min Kyu Kang g, Jin Hee Kim h, Young Suk Kim i, Hun Jung Kim j, Woo-Yoon Park k, Byoung Hyuck Kim b,l,*, Hak Jae Kim
doi : 10.1016/j.radonc.2023.109936
Volume 189, December 2023, 109936
Thymic epithelial tumour radiotherapy in the UK: A survey of current clinical practice
Stephen D. Robinson a,b,*, Abigail Gault c,d, Sangary Kathirgamakarthigeyan e, David Gilligan f,g, on behalf of the UK National Oncology Trainee Collaborative for Healthcare research NOTCH
doi : 10.1016/j.radonc.2023.109940
Volume 189, December 2023, 109940
Microbiome and metabolome dynamics during radiotherapy for prostate cancer
Willeke Danckaert a,b,c,*, Mathieu Spaas a,b,c, Nora Sundahl d, Aur´elie De Bruycker a,b,d, Val´erie Fonteyne a,b,c, Ellen De Paepe e, Carlos De Wagter a,b, Lynn Vanhaecke c,e,f, Piet Ost
doi : 10.1016/j.radonc.2023.109950
Volume 189, December 2023, 109950
The health-related quality of life of sarcoma patients treated with neoadjuvant versus adjuvant radiotherapy – Results of a multi-center observational study
Susanne Singer a,b,m,*,1, Sabine Semrau c,1, Henriette Golcher d, Katja Fechner d, Annett Kallies c, Sergio Zapata Bonilla b,e, Robert Grützmann d, Rainer Fietkau c, Torsten Kluba f, Christina Jentsch g, Dimosthenis Andreou h,i, Martin Bornh¨auser g,k,l, Jochen Schmitt j,k,l, Markus K. Schuler g, Martin Eichler
doi : 10.1016/j.radonc.2023.109913
Volume 189, December 2023, 109913
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models
Maria A. Smolle a, Dimosthenis Andreou a, Judith W¨olfel a, Ibtissam Acem b,c, Michiel Aj Van De Sande c,*, Lee Jeys d, Han Bonenkamp e, Rob Pollock f, Per-Ulf Tunn g, Rick Haas h, Florian Posch i, Robert J. Van Ginkel j, Cornelis Verhoef b, Bernadette Liegl-Atzwanger k, Dalia Moustafa-Hubmer l, Philipp J. Jost i, Andreas Leithner a, Joanna Szkandera
doi : 10.1016/j.radonc.2023.109944
Volume 189, December 2023, 109944
Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysis
Marcin Miszczyk a,b,*, Agata Suleja a,c, Szymon Sobel a, Maria Stec a, Artur Jan Chyrek d,h, Miros?aw Kolbusz e, Mateusz Spa?ek c, Aleksandra Nasiek a, Magdalena Stankiewicz f, Piotr Lelek f, Matthias Moll b, Adam Kluska d, Damian Kazalski e, Piotr Saniewski c, Konrad Kamini´ow a,g, Wojciech Maria Burchardt d,h, Piotr Wojcieszek f, Adam Chiche? d, Piotr Cicho´n e, Tomasz Krzysztofiak
doi : 10.1016/j.radonc.2023.109945
Volume 189, December 2023, 109945
Are 7.5 Gy×2 fractions more efficient than 6 Gy×3 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis
Faegheh Noorian a,b, Rosa Abellana b, Yaowen Zhang c, Antonio Herreros a,b, Clara Baltrons a, Vallentina Lancellota d, Luca Tagliaferri d, Sebastia Sabater f, Aureli Torne e, Angeles Rovirosa
doi : 10.1016/j.radonc.2023.109909
Volume 189, December 2023, 109909
Ultra-fast multi-parametric 4D-MRI image reconstruction for real-time applications using a downsampling-invariant deformable registration (D2R) model
Haonan Xiao a,b,*, Xinyang Han a, Shaohua Zhi a, Yat-Lam Wong a, Chenyang Liu a, Wen Li a, Weiwei Liu c, Weihu Wang c, Yibao Zhang c, Hao Wu c, Ho-Fun Victor Lee d, Lai-Yin Andy Cheung d, Hing-Chiu Chang e, Yen-Peng Liao f, Jie Deng f, Tian Li a,*, Jing Cai
doi : 10.1016/j.radonc.2023.109948
Volume 189, December 2023, 109948
Gating and intrafraction drift correction on a 1.5Â T MR-Linac: Clinical dosimetric benefits for upper abdominal tumors
Guus Grimbergen *, Sara L. Hackett , Fasco van Ommen , Astrid L.H.M.W. van Lier , Pim T.S. Borman , Lieke T.C. Meijers , Eline N. de Groot-van Breugel , Johannes C.J. de Boer , Bas W. Raaymakers , Martijn P.W. Intven , Gert J. Meijer
doi : 10.1016/j.radonc.2023.109932
Volume 189, December 2023, 109932
Development and validation of a machine learning model of radiation-induced hypothyroidism with clinical and dose–volume features
Mu-Hung Tsai a,b , Joseph T.C. Chang c , Hsi-Huei Lu d,e , Yuan-Hua Wu b , Tzu-Hui Pao b , Yung-Jen Cheng b , Wen-Yen Zheng b , Chen-Yu Chou c , Jing-Han Lin f , Tsung Yu g , Jung-Hsien Chiang
doi : 10.1016/j.radonc.2023.109911
Volume 189, December 2023, 109911
Stereotactic ablative radiotherapy and FAPα-based cancer vaccine suppresses metastatic tumor growth in 4T1 mouse breast cancer
Meihua Chen a,*, Ling Xiao a, Hongyuan Jia a, Shubin Wang a, Xiao Jiang a,b, Xudan Lei a, Qiming Zhai c, Jinyi Lang
doi : 10.1016/j.radonc.2023.109946
Volume 189, December 2023, 109946
The role of autophagy in hypoxia-induced radioresistance
Rhianna Mae Hill a, Matthew Fok a, Gabrielle Grundy a, Jason Luke Parsons b, Sonia Rocha
doi : 10.1016/j.radonc.2023.109951
Volume 189, December 2023, 109951
Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function
Martijn H. van der Ree a,b,c, Wiert F. Hoeksema a, Adrian Luca c, Jorrit Visser d, Brian V. Balgobind d, Michiel Zumbrink a, Raymond Spier a, Claudia Herrera-Siklody c, Justin Lee e, Matthew Bates f, Jim Daniel g, Clive Peedell g, Judit Boda-Heggemann h, Boris Rudic i, Roland Merten j, Edith M. Dieleman d, Cristopher A. Rinaldi k, Shahreen Ahmad l, John Whitaker k, Pranav Bhagirath a,k, Matthew Q. Hatton m, Stephen Riley m, Melanie Grehn n, Luis Schiappacasse o, Oliver Blanck n, Stephan Hohmann p, Etienne Pruvot c, Pieter G. Postema
doi : 10.1016/j.radonc.2023.109910
Volume 189, December 2023, 109910
Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platform
Jonas Willmann a,*, Ane L. Appelt b, Panagiotis Balermpas a, Brigitta G. Baumert c, Dirk de Ruysscher d, Morten Hoyer e, Coen Hurkmans f, Orit Kaidar-Person g, Icro Meattini h,i, Maximilian Niyazi j,k, Philip Poortmans l,m, Nick Reynaert n, Stephanie Tandini-Lang a, Yvette van der Linden o, Carsten Nieder p,q, Nicolaus Andratschke
doi : 10.1016/j.radonc.2023.109947
Volume 189, December 2023, 109947
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
Hazim S. Ababneh a, Andrew J. Yee b, Noopur S. Raje b, Sidney Martin a, Matthew J. Frigault b, Andrea K. Ng c, Chirayu G. Patel
doi : 10.1016/j.radonc.2023.109933
Volume 189, December 2023, 109933
Comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer�
Yu-Tzu Chiena, Yung-Shuo Kao
doi : 10.1016/j.radonc.2023.109919
Volume 189, December 2023, 109919
Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer�
Wee Loon Onga,b,c, Liying Zhanga, Andrew Loblaw
doi : 10.1016/j.radonc.2023.109918
Volume 189, December 2023, 109918
Letter to the editor regarding the article “Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4–10 brain metastases: A nonrandomized controlled trial� by Bodensohn et al
Chai Hong Rim
doi : 10.1016/j.radonc.2023.109851
Volume 189, December 2023, 109851
Letter to the editor of radiotherapy and oncology regarding the paper “Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4–10 brain metastases: A nonrandomized controlled trial » by Bodensohn et al.
Sofian Benkhaled a,? Christine Collen b Nicolas Jullian
doi : 10.1016/j.radonc.2023.109850
Volume 189, December 2023, 109850
Response to the letters to the editor of S. Benkhaled et al. and C.H. Rim regarding the article “Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4–10 brain metastases: A nonrandomized controlled trial� by Bodensohn et al.
Raphael Bodensohna,b, Maximilian Niyazia,b,c,d
doi : 10.1016/j.radonc.2023.109888
Volume 189, December 2023, 109888
